Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR12696770

03b0c194-f2d4-50cd-b529-84080dba9ffd

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • E2F_TARGETS+0.200
  • G2M_CHECKPOINT+0.200
  • MITOTIC_SPINDLE+0.200
  • SPERMATOGENESIS+0.200
  • KRAS_SIGNALING_DN+0.100
  • PANCREAS_BETA_CELLS+0.100
  • APICAL_JUNCTION+0.000
  • BILE_ACID_METABOLISM+0.000
  • COAGULATION+0.000
  • DNA_REPAIR+0.000

Top 10 suppressed

  • ALLOGRAFT_REJECTION-0.500
  • IL6_JAK_STAT3_SIGNALING-0.500
  • INFLAMMATORY_RESPONSE-0.400
  • INTERFERON_ALPHA_RESPONSE-0.400
  • INTERFERON_GAMMA_RESPONSE-0.400
  • OXIDATIVE_PHOSPHORYLATION-0.400
  • PI3K_AKT_MTOR_SIGNALING-0.400
  • COMPLEMENT-0.300
  • IL2_STAT5_SIGNALING-0.300
  • MYC_TARGETS_V1-0.300

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

5 twins match this tumor's tissue · 5 come from a different tissue of origin ← cross-tissue dominant

#SampleCancer typeSubtypecos similarity
1SRR13780248
lung-landscapes@6
cohortSC0.874
2BS_4E1G7E3G
brain-umap@2
ATRT0.865
3BS_4W68NV3M
brain-umap@2
medulloblastoma0.862
4266352
medullo-epn-umap@date-based
EPNEPN Tumor0.860
5SRR23303774
bladder-landscape@3
0.859
6BS_S1M423AB
brain-umap@2
Embryonal tumors0.854
7SRR8518343
breast-umap@18
E0.852
8SRR22247242
lung-landscapes@6
cohortSC0.851
9BS_W311713R
brain-umap@2
medulloblastoma0.848
10SRR6013518
lung-landscapes@6
cohortSQ10.847

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 6 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
E2F_TARGETS0.200Inavolisib— uncovered
G2M_CHECKPOINT0.200Inavolisib— uncovered
MITOTIC_SPINDLE0.200Inavolisib— uncovered
SPERMATOGENESIS0.200Inavolisib— uncovered
KRAS_SIGNALING_DN0.100Remibrutinib— uncovered
PANCREAS_BETA_CELLS0.100Cobimetinib— uncovered